DexCom, Inc. (DXCM)
91.06
-1.28
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.46
(+0.51%)
After-Hours: 20:00
DexCom Net Income (Quarterly) : 249.10M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 249.10M |
| March 31, 2026 | 199.50M |
| December 31, 2025 | 267.30M |
| September 30, 2025 | 283.80M |
| June 30, 2025 | 179.80M |
| March 31, 2025 | 105.40M |
| December 31, 2024 | 151.70M |
| September 30, 2024 | 134.60M |
| June 30, 2024 | 143.50M |
| March 31, 2024 | 146.40M |
| December 31, 2023 | 256.30M |
| September 30, 2023 | 120.70M |
| June 30, 2023 | 115.90M |
| March 31, 2023 | 48.60M |
| December 31, 2022 | 91.80M |
| September 30, 2022 | 101.20M |
| June 30, 2022 | 50.90M |
| March 31, 2022 | 97.30M |
| December 31, 2021 | -5.30M |
| September 30, 2021 | 87.30M |
| June 30, 2021 | 78.40M |
| March 31, 2021 | 56.50M |
| December 31, 2020 | 355.20M |
| September 30, 2020 | 72.20M |
| June 30, 2020 | 46.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.90M |
| December 31, 2019 | 92.70M |
| September 30, 2019 | 45.80M |
| June 30, 2019 | -10.50M |
| March 31, 2019 | -26.90M |
| December 31, 2018 | -179.70M |
| September 30, 2018 | 46.60M |
| June 30, 2018 | 30.20M |
| March 31, 2018 | -24.20M |
| December 31, 2017 | -9.40M |
| September 30, 2017 | -2.00M |
| June 30, 2017 | 2.90M |
| March 31, 2017 | -41.70M |
| December 31, 2016 | -7.40M |
| September 30, 2016 | -18.80M |
| June 30, 2016 | -20.20M |
| March 31, 2016 | -19.20M |
| December 31, 2015 | 1.50M |
| September 30, 2015 | -42.50M |
| June 30, 2015 | -3.70M |
| March 31, 2015 | -12.90M |
| December 31, 2014 | 1.30M |
| September 30, 2014 | -5.20M |
| June 30, 2014 | -6.00M |
| March 31, 2014 | -12.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| Insulet Corp. | 95.00M |
| Baxter International, Inc. | 135.00M |
| Globus Medical, Inc. | 151.57M |
| Stryker Corp. | 1.276B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.308B |
| Total Expenses (Quarterly) | 1.059B |
| EPS Diluted (Quarterly) | 0.6429 |
| Enterprise Value | 33.82B |
| Gross Profit Margin (Quarterly) | 63.44% |
| Profit Margin (Quarterly) | 19.04% |
| Earnings Yield | 2.78% |
| Operating Earnings Yield | 3.15% |
| Normalized Earnings Yield | 2.782 |